GUFIC BIOSCIENCES
Back to All Ratios
|
GUFIC BIOSCIENCES Last 5 Year Total Debt/Equity History
[Consolidated]
| Mar2025 | Mar2024 | |
|---|---|---|
| Total Debt/Equity(x) | 0.52 | 0.60 |
What is the latest Total Debt/Equity ratio of GUFIC BIOSCIENCES ?
| Year | Total Debt/Equity |
|---|---|
| Mar2025 | 0.52 |
| Mar2024 | 0.60 |
How is Total Debt/Equity of GUFIC BIOSCIENCES Trending?
| Years | Total Debt/Equity | % Change | |
|---|---|---|---|
| Mar2025 | 0.52 | -13.33 | |
| Mar2024 | 0.6 | - | |
Other Financial Ratios of GUFIC BIOSCIENCES
| Operational & Financial Ratios Earnings Per Share CEPS DPS Book NAV/Share Tax Rate | Margin Ratios Core EBITDA Margin EBIT Margin Pre Tax Margin PAT Margin Cash Profit Margin | Performance Ratios ROA ROE ROCE Asset Turnover Sales/Fixed Asset Working Capital/Sales | Efficiency Ratios Fixed Capital/Sales Receivable days Inventory Days Payable days | Valuation Parameters PER PCE Price/Book Yield EV/Net Sales EV/Core EBITDA EV/EBIT EV/CE M Cap / Sales | Growth Ratios Net Sales Growth Core EBITDA Growth EBIT Growth PAT Growth EPS Growth | Financial Stability Ratios Current Ratio Quick Ratio Interest Cover Total Debt/Mcap |
Compare Total Debt/Equity ratio of peers of GUFIC BIOSCIENCES
| Peers & Returns | Market Capitalization | 1 Week | 1 Month | 1 Year | ||
| GUFIC BIOSCIENCES | ₹2,879.6 Cr | -0.9% | -1.1% | -21.9% | Stock Analytics | |
| SUN PHARMACEUTICAL INDUSTRIES | ₹436,859.0 Cr | 4.2% | 5.3% | 1.1% | Stock Analytics | |
| DIVIS LABORATORIES | ₹176,618.0 Cr | 3.4% | 12.6% | 8.3% | Stock Analytics | |
| TORRENT PHARMACEUTICALS | ₹144,718.0 Cr | 2.2% | 4.1% | 28% | Stock Analytics | |
| CIPLA | ₹107,722.0 Cr | 2% | 11.5% | -13.4% | Stock Analytics | |
| DR REDDYS LABORATORIES | ₹106,081.0 Cr | -6.2% | 5.1% | 9.5% | Stock Analytics | |
GUFIC BIOSCIENCES Share Price vs Sensex
| Share Price Returns(%) | 1 Week | 1 Month | 1 Year |
| GUFIC BIOSCIENCES | -0.9% |
-1.1% |
-21.9% |
| SENSEX | -0.4% |
7.1% |
-4% |
You may also like the below Video Courses